Roberta C. Orsini

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach.

Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach.

Journal: Biomedicines
Published: August 02, 2021

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers.

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers.

Journal: Biomedicines
Published: January 07, 2021

Impact of Genetic Variations and Epigenetic Mechanisms on the Risk of Obesity.

Impact of Genetic Variations and Epigenetic Mechanisms on the Risk of Obesity.

Journal: International journal of molecular sciences
Published: November 09, 2020

Plasma phospholipid dysregulation in patients with cystathionine-β synthase deficiency.

Plasma phospholipid dysregulation in patients with cystathionine-β synthase deficiency.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: May 26, 2020

Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies.

Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies.

Journal: European journal of preventive cardiology
Published: May 16, 2020

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.

Journal: British journal of cancer
Published: March 17, 2017

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.

Journal: Scientific reports
Published: March 16, 2017

Everolimus induces Met inactivation by disrupting the FKBP12/Met complex.

Everolimus induces Met inactivation by disrupting the FKBP12/Met complex.

Journal: Oncotarget
Published: March 21, 2016

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status.

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status.

Journal: Oncotarget
Published: March 04, 2015
Showing 1-9 of 9

Last Updated: 09/26/2026